Clinical Trial Update: Mitomicin C for Prevention Postoperative Endoscopic Sinus Surgery Synechia and QOL in Chronic Rhinosinusitis [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating Mitomycin C to prevent postoperative nasal synechia and improve quality of life after endoscopic sinus surgery in chronic rhinos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinosinusitis

Drugs mentioned

• Mitomycin-C (mitomycin C)

Snippet

Sponsor: Mahidol University | Conditions: Chronic Rhinosinusitis, Postoperative Nasal Synerchia | Phase 3 | Status: COMPLETED